Evercore Begins Coverage on Cigna Group (NYSE:CI)

Evercore started coverage on shares of Cigna Group (NYSE:CI) in a research report issued on Wednesday, Marketbeat.com reports. The firm set an “in-line” rating and a $290.00 price target on the health services provider’s stock. Evercore’s price objective points to a potential upside of 6.05% from the company’s previous close.

Several other research firms also recently weighed in on CI. Wells Fargo & Company raised their target price on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Barclays raised their price objective on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 29th. Fifteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $337.10.

Cigna Group Price Performance

Shares of CI stock traded down $2.37 on Wednesday, reaching $273.46. 62,404 shares of the company were exchanged, compared to its average volume of 1,675,409. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The business has a 50-day moving average price of $283.56 and a 200 day moving average price of $280.84. The company has a market cap of $72.26 billion, a price-to-earnings ratio of 11.35, a P/E/G ratio of 0.97 and a beta of 0.31.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period last year, the company posted $7.20 EPS. Cigna Group’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Everett Neville sold 617 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 23,629 shares of company stock valued at $6,561,809. 0.60% of the stock is currently owned by insiders.

Institutional Trading of Cigna Group

Institutional investors have recently made changes to their positions in the company. Evercore Wealth Management LLC grew its position in Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after acquiring an additional 35 shares during the period. Cary Street Partners Investment Advisory LLC raised its holdings in Cigna Group by 11.0% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after buying an additional 36 shares during the period. Independence Bank of Kentucky lifted its position in Cigna Group by 2.6% in the second quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after buying an additional 37 shares during the last quarter. West Family Investments Inc. lifted its position in Cigna Group by 4.2% in the second quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock valued at $253,000 after buying an additional 37 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its stake in Cigna Group by 2.5% during the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after buying an additional 38 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.